XML 10 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Expenses    
Research and development $ 5,254,966 $ 1,362,438
General and administrative 11,416,586 2,540,446
Total expenses 16,671,552 3,902,884
Loss from operations (16,671,552) (3,902,884)
Foreign exchange losses (1,804) (8,376)
Investment income 629,602 158,288
Changes in fair value of the warrant liability (109,360,630)  
Net loss $ (125,404,384) $ (3,752,972)
Net loss per share, basic $ (2.86) $ (0.5)
Net loss per share, diluted $ (2.86) $ (0.5)
Weighted average shares outstanding, basic 43,900,426 7,568,981
Weighted average shares outstanding, diluted 43,900,426 7,568,981